Verve Therapeutics, Inc.
VERVDelisted Jul 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840574
Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Verve Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 134 | 157 | +23 |
| Shares | 63.9M | 74.7M | +10.9M (+17.0%) |
| Value | $847.0M | $1.04B | +$194.7M (+23.0%) |
New holders (43)
Institutions that held Verve Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (20)
Institutions that held Verve Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Artal Group S.A. | 300,000 | $3.98M |
| Avidity Partners Management LP | 285,334 | $3.78M |
| Logos Global Management LP | 215,000 | $2.85M |
| Farallon Capital Management, L.L.C. | 211,293 | $2.80M |
| Millennium Management LLC | 91,948 | $1.22M |
| HN Saltoro Capital, LP | 66,500 | $881.8K |
| Gsa Capital Partners LLP | 56,895 | $754.0K |
| Tudor Investment Corp Et Al | 31,744 | $420.9K |
| Jump Financial, LLC | 26,913 | $356.9K |
| PEAK6 Investments LLC | 18,000 | $238.7K |
| Penserra Capital Management LLC | 8,544 | $113.0K |
| Cary Street Partner Investment Advisory LLC | 1,000 | $13.3K |
| Belvedere Trading LLC | 121 | $1.60K |
| C M Bidwell & Associates Ltd | 101 | $1.34K |
| Headinvest, LLC | 100 | $1.18K |
| EverSource Wealth Advisors, LLC | 79 | $1.05K |
| Massmutual Trust Co FSB | 22 | $292 |
| Northwestern Mutual Wealth Management Co | 7 | $93 |
| Allworth Financial LP | 1 | $14 |
| Capital Advisors, Ltd. LLC | 31 | $0 |